Objectives: Medication safety program started at Riyadh city of Ministry of Health in 2014. Identifying, resolving and preventing drug therapy problems are the unique contributions of the pharmaceutical care practitioner. The research aimed to estimate cost-efficiency of Medication Safety program at the hospital in East province, Saudi Arabia by using American model of pharmacist intervention cost avoidance. Methods: This cross-sectional study with a 9-month recruitment period was conducted in a 300-bed public hospital through preventing and documentation of medication errors in adults and pediatrics at Ministry of Health hospitals in 2015. The program led by trained pharmacist and delivered basic patient safety in medical education to all healthcare professionals. The predictable cost calculated using International Study Model, expressed in USD, the cost measured were the expected results of medication errors outcome if not stopped; starting from physician visit, additional laboratory test, further treatment, hospital admission and critical care admission to death stage. Results: The total number of prevented medication errors were 3,378 at 805 prescribed to 805 patients with an estimated cost avoidance of avoiding medication errors was (98,195.97 USD) for the study period and (10,910 USD) per month. The pharmacist avoided medication errors with estimated cost avoidance of drugrelated problem (29 USD) per each mistake and (122 USD) per prescription and patient. The most type inquiries estimated cost avoidance was prescribing stage 86,939.05 USD (99.86%), followed by drugrelated errors 7,061.26 USD (7.2%) and dosage form-related errors 6,084.98 USD (6.2%). The highest drug of cost avoidance were Musculoskeletal and joint disease (8,397.2 USD) followed by Infections (5,731.17 USD) and Nutrition (4,717.99 USD), while the largest drug of cost avoidance was Paracetamol Injection (5,812.17 USD), followed by oral Ferrous Sulfate (3,562.79 USD) and Ceftriaxone 1g (2,861.70 USD). Conclusion: Medication safety program is a cost-efficiency simulation at the public hospital in Saudi Arabia, prevents medication disasters, improve patient safety. Increasing drug safety program associated with preventing drug-related problems and cost avoidance simulation for Healthcare development and better care and better patient consequences.
INTRODUCTION
Quality patient care is a significance issue in all healthcare sectors; however, clinical errors are known to compromise patient safety. After recent directing events in which preventable failures in healthcare were recognized, patient safety remains high on the clinical and policy agenda in health systems. The established paradigm for studying medical decision-making is definitely attempted in a setting of vulnerability concerning the results and saving cost of programs and interferences of health care. Thusly, two arrangements of related choices should be taken: (1) those concerning proper administration arrangement based on existing data (from the earlier choice); and (2)benefit-cost analyses those which are calling for additional information collection in order to overcome earlier errors from a previous decision. 1 The choice regarding prolific service arrangement, based on collected data, includes individual the endorsement related with the best choice result (from the earlier decision). 1, 2 Inside the assessment of health technologies, choice settlements are the costs and impacts related with the considered interventions. Usually, these adjustments have been merged to frame Incremental Cost-Effectiveness Ratio (ICER) with the ideal involvement recognized as the one that produces the biggest ICER that falls under an external set limit. 3 By unequivocally consolidating, the choice settlements (effects and costs) can form a net benefit for every intervention (t) joined either in health outcomes or financial terms. 4, 5 Drug-Related Problems (DRPs), its health related and monetary weights which include Medication Errors (MEs), Adverse Drug Reactions (ADRs) and Adverse Drug Events (ADEs) have brought about fundamentals to guarantee enhanced medicine safety Programs. 6, 7 National Patient Safety Goal (NPSG) focuses on the risk points of medication reconciliation. The elements of performance in this NPSG are planned to help organizations reduce negative patient outcomes associated with medication inconsistencies. 8 Measurement of DRPs as well as its detection are basic to the distinctive proof of fundamental causes and making of patient care plans. 9, 10 The study conducted by Bates DW et al. the incidence of adverse drug events was 6.5 per 100 admissions and 28% were preventable. The ADEs and preventable contributed with an increased length of stay of 2.2 to 4.6 days and to an increase in cost of medication by 2,595 to 4,685 USD. 11 The cost showed in this study is far less than the cost incurred by the Saudi hospital during the conduct of the study. Another Study conducted by Classen DC et al. found that medication errors increased the cost of medication at the hospital by 2,262 USD and an increased risk of death of 1.88 fold. 12 The other studies in other countries could be unrealistic as the cost of medications differ across countries -this is according to the country's health system. Rottenkolber D et al. conducted a similar study where they found that the cost of medication errors were 1,033 USD for each person. 13 There are few studies conducted related on cost impact of medication safety program. However, Chen CC et al. revealed that the benefit/cost ratio increased from 4.29 to 9.36 and average admission days decreased by 2 days after the on-ward deployment of a clinical pharmacist. 14 In addition, the total cost avoidance was 103,073,160 -224,590,140 US $ annually. Another study by Najafzadeh M et al. found 52% reduced of medication reconciliation discrepancies and total saved was 175,306 US $ in the study period. 15 Medication reconciliation by pharmacists at hospital discharge is a possible strategy to diminish medication discrepancies and consequent ADEs. In Saudi Arabia, because of the increasing problem of medical errors and expanding media attention, health associations has been presently seeking after efforts to enhance quality and safety of overall medicinal services. A few activities have been implemented to boost safety mostly through setting up roles and starting accreditation plans. 8 A recent study conducted by Alomi YA et al. To explore the cost of drug related problems in Saudi Arabia from patients and healthcare professional viewpoints. The study found the estimated average cost per each medication error problem and per patient cost were (762.67) and (1347.38) respectively. 16 To the best of our knowledge, no comprehensive scientific study has explored these challenges and barriers in all Healthcare Facilities (HCFs) across the Kingdom of Saudi Arabia (KSA). The research aimed to estimate cost-efficiency of Medication Safety program at the hospital in Riyadh city, Saudi Arabia by using American model of pharmacist intervention cost avoidance.
METHODS
This cross-sectional study with a 9-month recruitment period was conducted in a 300-bed public hospital through preventing and documentation of medication errors in adults and pediatrics at Ministry of Health hospitals at Riyadh, Saudi Arabia in 2015. The study included inpatient sections of the hospital. The hospital services cover a range of medical offerings from basic health care to Adults Endocrinology, Adults Nephrology Pediatrics, Adults Cardiology, Adults Internal Medicine, Adults Surgery, Adults critical care, The Neonatal Intensive Care Unit (NICU), The Pediatric Intensive Care Unit, Obstetrics and Gynecology in addition to ambulatory care services and emergency services. Also, the hospital pharmacy offers very comprehensive pharmaceutical services including inpatient pharmacy, ambulatory care pharmacy, Total Parenteral Nutrition (TPN) services, drug information services and computerized physician order entry system inpatient and outpatient units. Also, the clinical pharmacist shared in the round with the medical team and patient counseling clinics. Before three years in 2014, the pharmacy department established medication safety program. 17 Medication safety program started at Riyadh Region in 2013. National medication safety program of Ministry of Health and Central committee of medication committee it headed by first author and Riyadh Regional Medication safety committee headed by second author. In particular, a hospital medication safety program managed by part-time pharmacist and the program consisted of medication officer and local committee of medication safety. The officer monitors all medication errors, adverse drug reaction, drug quality system inside the hospital, Institute Safety Medication Practice (ISMP) guidelines, 18-21 local standard of accreditation body (Saudi Central Board of Health Care Accreditation) standards and medication safety of Joint commission of Hospital accreditation from United States of America. 8, 22 They also felt accountable for medication safety course to all health care professional, physician, pharmacist, nurses etc. and report all medication safety related issues to higher administration and MOH. Medication officers are responsible for documenting Medication Errors (MEs), Adverse Drug Reactions (ADRs) using the different forms of MEs and ADRs forms. All errors or unforeseen events related with the medication system or a step in the medication process shall be reported using the medication error notification form/medication error sheet whether or not the error reached the patient. The medical error form consists of 2 parts and 40 items including types and causes of medical errors. The form mainly consisted of patient information, description of errors -date and time, medical product involved in the event, impact of the error, consequences, intervention, the sources of medication errors and qualification of committing errors. Suspected medications, drug classification, stage of medication orders, details of reporter, route of administration for medication, the type of medication errors, description and causes of errors, agreement to prevent the errors and the significance of medication errors by using National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) system. 23 The likely cost calculated using International Study Model, expressed in USD, the cost measured were the expected results of drug-related problems outcome of drug information services if not stopped and were not answered; starting from physician visit, additional laboratory test, more treatment, hospital admission and critical care admission to death stage. 24, 25 One way sensitivity analysis was done for a discount of prices list and variety of wage cost with 10-20%. The format analyzed through the Microsoft Excel Sheet Version 10 th . The study was conducted according to the ethics guidelines set out in the Declaration of Helsinki and consent from was obtained from the institution.
RESULTS
The total number of prevented medication errors were 3,378 at 805 prescribed to 805 patients with an estimated cost avoidance of avoiding medication errors was (98,195.97 USD) for the study period and (10,910 USD) per month. The pharmacist avoided medication errors with estimated cost avoidance of drug-related problem (29 USD) per each mistake and (122 USD) per prescription and patient. The highest cost avoidance (89.1%) came from predictable age (18-more than 65) while (8.28%) from pediatrics The most type inquiries estimated cost avoidance was prescribing stage 86,939.05 USD (99.86%), while the most cost avoidance of type of errors was prescriber related and general errors 83,707.98 USD (85.2%), followed by drug-related errors 7,061.26 USD (7.2%) and dosage form-related errors 6,084.98 USD (6.2%) ( 
DISCUSSION
This study established the cost benefit and prevention of medication errors due to the interference of pharmacist at the hospital in Riyadh city, Saudi Arabia. The number of pharmacist interventions in medication orders greatly enlarged after the on-ward arrangement of pharmacist, which resulted in a substantial cost benefit, fewer admission days and probably fewer MEs. There were obviously more interventions about medication duration or quantity, ideas of more appropriate medications and the finding of MEs after the pharmacist's contribution. The benefitcost analysis doubled after the on-ward deployment of a pharmacist through medication safety program. The general administration of pharmaceutical care underway pharmacy practice as part of pharmacy strategic plan in Saudi Arabia. The previously study by Chen C et al. 14 The predictable cost saving was calculated conventionally by a 1 day cost of the intervened medications. Moreover, the estimated cost avoidance was also calculated orthodoxly based on only 2 extra days of admission if ADEs occurred, although this may have resulted in more than 2 days of admission according to the Chen C et al. 11 Other study by Najafzadeh M et al. found contrasted from our results. 15 The size of cost avoidance observed in studies is likely to depend on the settings in which the economic evaluation was conducted beside it likely to depend on the health care discipline, intensity of care, data collection methods and cost analysis.
In the study, the most cost avoidance came from prescribing stage because most of medical errors were related to the prescribing stage (prescriber related medication errors). During this period, the hospital did not implement e-prescribing, drug altering system or clinical decision support system to prevent medication errors. The highest categories of prescription cost avoidance was muscle and joint specially pain management, nutrition and antibiotics. Medications for pain management had several adverse drugs reaction and very to committing error. The majority of these errors were "wrong strength" and "wrong dosage". That's impact of complications have a significant impact on total health care costs. Similar complications occurred in the medications for nutrition or antibiotics used (top cost avoidance). However, other studies highlighted that the antimicrobials have to be in the top of most commonly group of drugs involved. 26, 27 The majority of findings was problematic to compare with previous studies because rarely existed of research variables and to the best of our knowledge, there is no study relating to this. The study showed excellent role of pharmacist through prevention of medication errors. The pharmacists practicing under this program are in a better position to impact use of medications, prevent unwanted side effects and financially benefits. Therefore, this integration presents an opportunity for clinical pharmacist to contribute to the medical Institute. Composed they pursued a low-tech, low-cost strategy for reaching their goal. The cost avoidance related of pharmacist impact is part of new pharmacy strategic planning with new vision 2030 in Kingdom of Saudi Arabia. [28] [29] 
CONCLUSION
The pharmacists play a very important role, not only in medication safety, but also in cost saving. The implementation of medication safety program is reasonable. It prevented medication related problems and improve patient's clinical outcomes. Besides, the program prevents additional economic burden on healthcare system at Ministry of Hospitals in Kingdom of Saudi Arabia. Although, there is considerable opportunity for further improvement.
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